Greenwich Lifesciences Inc (GLSI)
Healthcare
Biotechnology
13.50 $
+0.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Greenwich Lifesciences Inc (GLSI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -9.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -0.1 | -0.1 | -0.3 | -1.2 | -4.3 | -6.2 | -6.5 | -7.3 | -9.9 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | 0.2 | 0.7 | 0.7 | 1.7 | 2.4 | 7.3 | 6.8 | |
| – | 0.2 | 0.2 | 0.7 | 0.7 | – | – | – | – | |
| 1.4 | 1.6 | 2.9 | 0.0 | -0.4 | -0.1 | 0.0 | 1.3 | 2.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -0.1 | – | – | 30 | 3.1 | -7.5 | 0.0 | – | – | |
| – | 0.1 | 0.2 | -0.4 | -0.3 | – | – | – | – | |
| -0.1 | 0.2 | 0.2 | 30 | 2.8 | -7.5 | 0.0 | 4.4 | 12 | |
| -0.3 | 0.1 | -0.1 | 29 | -1.5 | -14 | -6.5 | -2.9 | 2.1 | |
| -0.1 | -0.1 | -0.3 | -1.2 | -4.3 | -6.2 | -6.5 | -7.3 | -9.9 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.